Affiliation:
1. Cardiology Department, Liverpool Heart and Chest Hospital, Liverpool, UK
Abstract
Guidelines help clinicians to deliver high-quality care with therapies based on up-to-date evidence. There has been significant progress in the management of heart failure with regards to both medication and cardiac device therapy. These advances have been incorporated into national and international guidelines with varying degrees of success. This article reviews current guidance from the National Institute of Health and Care Excellence in the UK and compares this with European Society of Cardiology guidelines, and evaluates how differences between them may impact on clinical practice.
Publisher
Radcliffe Media Media Ltd
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference52 articles.
1. Malik A, Brito D, Vaqar S, Chhabra L. Congestive Heart Failure. Treasure Island, FL: StatsPearls Publishing, 2022.
2. Bragazzi NL, Zhong W, Shu J, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol 2021;28:1682–90. https://doi.org/10.1093/eurjpc/zwaa147; PMID: 33571994.
3. National Institute for Cardiovascular Outlines Research. National Cardiac Audit Programme. 2022. https://www.nicor.org.uk/national-cardiac-audit-programme/ (accessed 4 March 2023).
4. National Institute of Health and Care Excellence. Chronic heart failure in adults: diagnosis and management. London: NICE, 2018. https://www.nice.org.uk/guidance/ng106 (accessed 4 March 2023).
5. Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol 2016;13:368–78. https://doi.org/10.1038/nrcardio.2016.25; PMID: 26935038.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献